Miura Y - Search Results

1

Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view.

Tanaka J, Akita T, Ko K, Miura Y, Satake M; Epidemiological Research Group on Viral Hepatitis and its Long -term Course, Ministry of Health, Labour and Welfare of Japan. Tanaka J, et al. Among authors: miura y. Hepatol Res. 2019 Sep;49(9):990-1002. doi: 10.1111/hepr.13417. Epub 2019 Aug 22. Hepatol Res. 2019. PMID: 31364248 Free PMC article. Review.

2

[A nationwide survey for implementation of Health Japan 21 anti-smoking countermeasures in municipalities throughout Japan].

Shinmura H, Wakabayashi C, Kunisawa N, Kayaba K, Miura Y, Ojima T, Yanagawa H. Shinmura H, et al. Among authors: miura y. Nihon Koshu Eisei Zasshi. 2008 Mar;55(3):170-6. Nihon Koshu Eisei Zasshi. 2008. PMID: 18453144 Japanese.

3

A pilot study to build a database on seven anti-hypertensive drugs.

Fujita T, Miura Y, Mayama T. Fujita T, et al. Among authors: miura y. Pharmacoepidemiol Drug Saf. 2005 Jan;14(1):41-6. doi: 10.1002/pds.1021. Pharmacoepidemiol Drug Saf. 2005. PMID: 15534857

4

The conformational properties of alamethicin in ethanol studied by NMR.

Miura Y. Miura Y. Eur Biophys J. 2024 Jun 8. doi: 10.1007/s00249-024-01711-1. Online ahead of print. Eur Biophys J. 2024. PMID: 38849514

5

Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy.

Tokura D, Konarita K, Suzuki M, Ogata K, Honda Y, Miura Y, Nishiyama N, Nomoto T. Tokura D, et al. Among authors: miura y. J Control Release. 2024 Jun 8;371:445-454. doi: 10.1016/j.jconrel.2024.06.006. Online ahead of print. J Control Release. 2024. PMID: 38844180 Free article.

6

Boron agent delivery platforms based on natural products for boron neutron capture therapy.

Kawasaki R, Miura Y, Kono N, Fujita S, Yamana K, Ikeda A. Kawasaki R, et al. Among authors: miura y. ChemMedChem. 2024 Jun 3:e202400323. doi: 10.1002/cmdc.202400323. Online ahead of print. ChemMedChem. 2024. PMID: 38830821

7

The presence of hiatal hernia is a significant predictor for symptomatic recurrence after cessation of vonoprazan therapy for gastroesophageal reflux disease: a long-term observational study.

Shinozaki S, Osawa H, Miura Y, Sakamoto H, Hayashi Y, Yano T, Despott EJ, Yamamoto H. Shinozaki S, et al. Among authors: miura y. Scand J Gastroenterol. 2024 May 31:1-7. doi: 10.1080/00365521.2024.2355351. Online ahead of print. Scand J Gastroenterol. 2024. PMID: 38821110

8

Bayesian optimization of glycopolymer structures for the interaction with cholera toxin B subunit.

Nagao M, Nakahara O, Zhou X, Matsumoto H, Miura Y. Nagao M, et al. Among authors: miura y. Nanoscale. 2024 May 31. doi: 10.1039/d4nr00915k. Online ahead of print. Nanoscale. 2024. PMID: 38819090

9

Traction Devices May Not Affect the Vertical Margin Distance in the Endoscopic Submucosal Dissection of Rectal Neuroendocrine Tumors.

Hayasaka J, Miura Y, Yamashita S, Matsui A, Kikuchi D, Takazawa Y, Hoteya S. Hayasaka J, et al. Among authors: miura y. Cureus. 2024 Apr 25;16(4):e58976. doi: 10.7759/cureus.58976. eCollection 2024 Apr. Cureus. 2024. PMID: 38800345 Free PMC article.

10

Laser Patterning of Porous Support Membranes to Enhance the Effective Surface Area of Thin-Film Composite-Facilitated Transport Membranes for CO₂ Separation.

Liu Y, Nakamura D, Gao J, Imamura K, Aki S, Nagai Y, Taniguchi I, Fujiwara K, Horii R, Miura Y, Hoshino Y. Liu Y, et al. Among authors: miura y. ACS Appl Mater Interfaces. 2024 Jun 5;16(22):29112-29120. doi: 10.1021/acsami.4c01260. Epub 2024 May 18. ACS Appl Mater Interfaces. 2024. PMID: 38761179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,473 results

Search Page